R Scott Greer - Net Worth and Insider Trading
R Scott Greer Net Worth
The estimated net worth of R Scott Greer is at least $233,377 dollars as of 2024-11-13. R Scott Greer is the Director of Nektar Therapeutics and owns about 176,574 shares of Nektar Therapeutics (NKTR) stock worth over $233,078. R Scott Greer is the Director of Aravive Inc and owns about 4,179 shares of Aravive Inc (ARAV) stock worth over $168. R Scott Greer is also the Director of Sientra Inc and owns about 5,266 shares of Sientra Inc (SIENQ) stock worth over $132. Details can be seen in R Scott Greer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R Scott Greer has not made any transactions after 2020-07-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of R Scott Greer
R Scott Greer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Scott Greer owns 6 companies in total, including Nektar Therapeutics (NKTR) , Inogen Inc (INGN) , and Sientra Inc (SIENQ) among others .
Click here to see the complete history of R Scott Greer’s form 4 insider trades.
Insider Ownership Summary of R Scott Greer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2020-07-09 | director |
| INGN | Inogen Inc | 2015-08-03 | director |
| SIENQ | Sientra Inc | 2018-05-07 | director |
 | | 2015-11-11 | director |
| | 2010-06-03 | director |
| | 2003-05-27 | director |
R Scott Greer Latest Holdings Summary
R Scott Greer currently owns a total of 3 stocks. Among these stocks, R Scott Greer owns 176,574 shares of Nektar Therapeutics (NKTR) as of July 9, 2020, with a value of $233,078 and a weighting of 99.87%. R Scott Greer owns 4,179 shares of Aravive Inc (ARAV) as of November 11, 2015, with a value of $168 and a weighting of 0.07%. R Scott Greer also owns 5,266 shares of Sientra Inc (SIENQ) as of May 7, 2018, with a value of $132 and a weighting of 0.06%.
Latest Holdings of R Scott Greer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2020-07-09 | 176,574 | 1.32 | 233,078 |
| ARAV | Aravive Inc | 2015-11-11 | 4,179 | 0.04 | 168 |
| SIENQ | Sientra Inc | 2018-05-07 | 5,266 | 0.03 | 132 |
Holding Weightings of R Scott Greer
R Scott Greer Form 4 Trading Tracker
According to the SEC Form 4 filings, R Scott Greer has made a total of 1 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nektar Therapeutics is the sale of 15,009 shares on July 9, 2020, which brought R Scott Greer around $375,225.
According to the SEC Form 4 filings, R Scott Greer has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the acquisition of 1,667 shares on November 11, 2015, which cost R Scott Greer around $101,700.
According to the SEC Form 4 filings, R Scott Greer has made a total of 0 transactions in Sientra Inc (SIENQ) over the past 5 years. The most-recent trade in Sientra Inc is the acquisition of 1,111 shares on May 7, 2018, which cost R Scott Greer around $149,998.
Insider Trading History of R Scott Greer
- 1
R Scott Greer Trading Performance
GuruFocus tracks the stock performance after each of R Scott Greer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Scott Greer is 0.68%. GuruFocus also compares R Scott Greer's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Scott Greer within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Scott Greer's insider trading performs compared to the benchmark.
Performance of R Scott Greer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.61 | | | | | |
| Relative Return to S&P 500(%) | 11.57 | | | | | |
R Scott Greer Ownership Network
Ownership Network List of R Scott Greer
Ownership Network Relation of R Scott Greer
R Scott Greer Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
R Scott Greer is the director of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, R Scott Greer made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
R Scott Greer Mailing Address
Above is the net worth, insider trading, and ownership report for R Scott Greer. You might contact R Scott Greer via mailing address: 6207 E. Indian Bend Rd, Paradise Valley Az 85253.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
